Integrated Diagnostics Gross Profit vs. Price To Sales

IDHC Stock   0.41  0.01  2.38%   
Based on Integrated Diagnostics' profitability indicators, Integrated Diagnostics Holdings may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Integrated Diagnostics' ability to earn profits and add value for shareholders.
For Integrated Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Integrated Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Integrated Diagnostics Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Integrated Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Integrated Diagnostics Holdings over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Integrated Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integrated Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integrated Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Integrated Diagnostics Price To Sales vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Integrated Diagnostics's current stock value. Our valuation model uses many indicators to compare Integrated Diagnostics value to that of its competitors to determine the firm's financial worth.
Integrated Diagnostics Holdings is currently regarded as number one stock in gross profit category among its peers. It also is currently regarded as number one stock in price to sales category among its peers . The ratio of Gross Profit to Price To Sales for Integrated Diagnostics Holdings is about  54,766,894,531 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integrated Diagnostics' earnings, one of the primary drivers of an investment's value.

Integrated Price To Sales vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Integrated Diagnostics

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
2.8 B
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Integrated Diagnostics

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.05 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Integrated Price To Sales Comparison

Integrated Diagnostics is currently under evaluation in price to sales category among its peers.

Integrated Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Integrated Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Integrated Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Integrated Diagnostics' important profitability drivers and their relationship over time.

Use Integrated Diagnostics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Integrated Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Integrated Diagnostics Pair Trading

Integrated Diagnostics Holdings Pair Trading Analysis

The ability to find closely correlated positions to Integrated Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Integrated Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Integrated Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Integrated Diagnostics Holdings to buy it.
The correlation of Integrated Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Integrated Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Integrated Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Integrated Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Integrated Diagnostics position

In addition to having Integrated Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Volatility ETFs Thematic Idea Now

Volatility ETFs
Volatility ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.